or Try an Advanced Search...

    Blastoma Stocks List

    Symbol Grade Name % Change
    UTHR C United Therapeutics Corporation 0.83
    SGMO C Sangamo BioSciences, Inc. 0.51
    NVCR C NovoCure Limited 1.36
    KZIA C Kazia Therapeutics Limited -1.43
    MBRX C Moleculin Biotech, Inc. 5.99
    FENC D Fennec Pharmaceuticals Inc. 1.72
    CNSP D CNS Pharmaceuticals, Inc. 5.18
    CLDX F Celldex Therapeutics, Inc. -0.68
    CLLS F Cellectis S.A. -2.62
    YMAB F Y-mAbs Therapeutics, Inc. -4.17
    View As Page of Charts
    Related Industries: Biotechnology Medical Instruments & Supplies
    Related Stock Lists: Cancer Glioblastoma Medicine Oncology Brain Tumor Biopharmaceutical Chemotherapy Solid Tumors Biotechnology Cancer Treatment Clinical Development Clinical Medicine Ovarian Cancer Acute Myeloid Leukemia Antineoplastic Drugs CD19 Cancer Cell Chronic Lymphocytic Leukemia Hematologic Malignancies Lymphocytic Leukemia

    Related ETFs - A few ETFs which own one or more of the above listed Blastoma stocks.

    Symbol Grade Name Weight
    PBE D PowerShares Dynamic Biotech & Genome 5.74
    FTXH D First Trust Nasdaq Pharmaceuticals ETF 3.9
    PJP D PowerShares Dynamic Pharmaceuticals 3.7
    FBT D First Trust Amex Biotech Index Fund 3.64
    GLRY A Inspire Faithward Mid Cap Momentum ESG ETF 3.33
    View all Blastoma ETFs...
    Compare ETFs
    Compare FTXH to PJP Compare PBE to GLRY Compare PJP to GLRY

        Blastoma Stocks Recent News

        Date Stock Title
        Nov 21 NVCR Novocure secures FDA approval for add-ons to brain cancer treatment wearable
        Nov 21 NVCR Novocure gets FDA approval for its HFE transducer arrays for glioblastoma treatment
        Nov 21 NVCR Novocure Data at 2024 SNO Annual Meeting Highlights Product Innovation and Real-World Evidence for Tumor Treating Fields (TTFields) Therapy in Glioblastoma
        Nov 21 NVCR FDA Approves Novocure’s Innovative HFE Transducer Arrays for Use With Optune Gio® for Glioblastoma
        Nov 20 UTHR Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
        Nov 20 CLDX Celldex Announces First Patient Dosed in Phase 1 Healthy Volunteer Study of CDX-622, a Bispecific Antibody, for the Treatment of Inflammatory Diseases
        Nov 20 CLDX Beyond The Numbers: 11 Analysts Discuss Celldex Therapeutics Stock
        Nov 19 SGMO Sangamo stock climbs 12% post-market on FDA update for ST-503
        Nov 19 SGMO Sangamo Therapeutics Announces U.S. FDA Clearance of IND Application for ST-503 for the Treatment of Idiopathic Small Fiber Neuropathy, a Type of Chronic Neuropathic Pain
        Nov 18 CNSP CNS Pharmaceuticals Announces Abstract Accepted for Poster Presentation at the 29th Annual Meeting of the Society for Neuro-Oncology (SNO 2024)
        Nov 15 UTHR United Therapeutics: Competitive Advantages At Such Cheap Multiples Scream Buy
        Nov 15 CNSP CNS Pharmaceuticals reports Q3 results
        Nov 15 CNSP CNS Pharmaceuticals Reports Third Quarter 2024 Financial Results
        Nov 15 UTHR United Therapeutics Expands Into Organ Transplants, But Tyvaso's Legal Battles Loom
        Nov 15 SGMO Sangamo Therapeutics Third Quarter 2024 Earnings: Beats Expectations
        Related Industries: Biotechnology Medical Instruments & Supplies
        Related Stock Lists: Cancer Glioblastoma Oncology Biotechnology Brain Tumor Medicine Neuroblastoma Brain Cancer Chemotherapy Ovarian Cancer Stage Pharmaceutical Transcription Transcription Factor Transcription Factors ATM Acute Myeloid Leukemia Aging Associated Diseases Alcohol Antineoplastic Drugs Biopharmaceutical
        Blastoma

        A blastoma is a type of cancer, more common in children, that is caused by malignancies in precursor cells, often called blasts. Examples are nephroblastoma, medulloblastoma, and retinoblastoma. The suffix -blastoma is used to imply a tumor of primitive, incompletely differentiated (or precursor) cells, e.g., chondroblastoma is composed of cells resembling the precursor of chondrocytes.

        More about Blastoma
        Browse All Tags